Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials. [electronic resource]
Producer: 20170801Description: 622-628 p. digitalISSN:- 1527-7755
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Hepatocellular -- drug therapy
- Clinical Trials, Phase III as Topic
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Randomized Controlled Trials as Topic
- Sorafenib
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.